Man Group’s Sangamo Therapeutics SGMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,185
| Closed | -$10.4K | – | 2097 |
|
|
2024
Q4 | $10.4K | Buy |
+10,185
| New | +$10.4K | ﹤0.01% | 1801 |
|
|
2023
Q4 | – | Hold |
0
| – | -$78.5K | – | 2107 |
|
|
2023
Q3 | – | Sell |
-157,850
| Closed | -$205K | – | 1821 |
|
|
2023
Q2 | $205K | Buy |
+157,850
| New | +$205K | ﹤0.01% | 1774 |
|
|
2023
Q1 | – | Sell |
-144,740
| Closed | -$454K | – | 1810 |
|
|
2022
Q4 | $454K | Buy |
144,740
+104,801
| +262% | +$329K | ﹤0.01% | 1533 |
|
|
2022
Q3 | $196K | Buy |
+39,939
| New | +$196K | ﹤0.01% | 1742 |
|
|
2021
Q1 | – | Sell |
-135,166
| Closed | -$2.11M | – | 1974 |
|
|
2020
Q4 | $2.11M | Sell |
135,166
-19,283
| -12% | -$301K | 0.01% | 1183 |
|
|
2020
Q3 | $1.46M | Buy |
154,449
+23,310
| +18% | +$220K | 0.01% | 1285 |
|
|
2020
Q2 | $1.18M | Buy |
131,139
+75,190
| +134% | +$674K | 0.01% | 1228 |
|
|
2020
Q1 | $356K | Buy |
55,949
+17,000
| +44% | +$108K | ﹤0.01% | 1342 |
|
|
2019
Q4 | $326K | Hold |
38,949
| – | – | ﹤0.01% | 1654 |
|
|
2019
Q3 | $352K | Sell |
38,949
-69,849
| -64% | -$631K | ﹤0.01% | 1630 |
|
|
2019
Q2 | $1.17M | Buy |
108,798
+6,000
| +6% | +$64.6K | ﹤0.01% | 1474 |
|
|
2019
Q1 | $981K | Buy |
102,798
+33,520
| +48% | +$320K | ﹤0.01% | 1575 |
|
|
2018
Q4 | $795K | Sell |
69,278
-73,974
| -52% | -$849K | ﹤0.01% | 1514 |
|
|
2018
Q3 | $2.43M | Buy |
143,252
+160
| +0.1% | +$2.71K | 0.01% | 1329 |
|
|
2018
Q2 | $2.03M | Buy |
143,092
+85,900
| +150% | +$1.22M | 0.01% | 1341 |
|
|
2018
Q1 | $1.09M | Buy |
+57,192
| New | +$1.09M | 0.01% | 1469 |
|